Funding for this research was provided by:
Metcalfe
Article History
Received: 24 February 2021
Accepted: 7 March 2021
First Online: 15 March 2021
Declarations
:
: AJK—None. DSH—Grants from Bayer, Lilly, Genentech, LOXO, Pfizer, Amgen, Mirati, Ignyta, Merck, Daichii-Sanko, Eisai, Adaptimmune, Abbvie, Astra-Zeneca, BMS, Genmab, Infinity, Kite, Kyowa, Medimmune, Molecular Template, Novartis, and Takeda; personal fees from Mirna and LOXO; other from Bayer, Baxter, Guidepoint Global, Oncoresponse, Janssen, and Molecular Match; all outside the submitted work. GCG—None.